Wellington Management Group LLP Purchases New Stake in Nutrien Ltd. $NTR

Wellington Management Group LLP purchased a new stake in shares of Nutrien Ltd. (NYSE:NTR) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 10,389,040 shares of the company’s stock, valued at approximately $654,081,000.

Other large investors have also added to or reduced their stakes in the company. Montag A & Associates Inc. raised its stake in shares of Nutrien by 310.7% during the fourth quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock valued at $26,000 after acquiring an additional 320 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. boosted its holdings in shares of Nutrien by 1,014.0% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 479 shares of the company’s stock worth $30,000 after purchasing an additional 436 shares during the period. Global Retirement Partners LLC bought a new stake in shares of Nutrien in the second quarter worth about $30,000. Evolution Wealth Management Inc. bought a new stake in shares of Nutrien in the first quarter worth about $32,000. Finally, Allied Private Wealth LLC purchased a new position in Nutrien during the 2nd quarter valued at about $33,000. Institutional investors own 63.10% of the company’s stock.

Nutrien Stock Performance

Nutrien stock opened at $73.64 on Friday. The stock’s 50 day simple moving average is $67.33 and its two-hundred day simple moving average is $70.56. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.86 and a current ratio of 1.39. The stock has a market cap of $35.23 billion, a price-to-earnings ratio of 14.91, a PEG ratio of 0.78 and a beta of 0.61. Nutrien Ltd. has a fifty-two week low of $53.03 and a fifty-two week high of $85.36.

Nutrien (NYSE:NTR) last announced its earnings results on Wednesday, August 5th. The company reported $2.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.70 by ($0.09). Nutrien had a return on equity of 8.88% and a net margin of 8.44%.The firm had revenue of $10.81 billion during the quarter, compared to the consensus estimate of $10.44 billion. During the same period in the prior year, the company posted $2.65 EPS. The firm’s revenue was up 3.6% on a year-over-year basis. As a group, analysts expect that Nutrien Ltd. will post 4.71 earnings per share for the current fiscal year.

Nutrien Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 16th. Investors of record on Tuesday, September 29th will be paid a $0.55 dividend. This represents a $2.20 annualized dividend and a yield of 3.0%. The ex-dividend date of this dividend is Tuesday, September 29th. Nutrien’s dividend payout ratio is presently 44.53%.

Analyst Upgrades and Downgrades

A number of research analysts have commented on NTR shares. Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of Nutrien in a research report on Monday, August 10th. UBS Group reduced their target price on Nutrien from $67.00 to $65.00 and set a “sell” rating on the stock in a research note on Monday, May 11th. Raymond James Financial upgraded Nutrien from a “market perform” rating to an “outperform” rating and upped their target price for the company from $74.00 to $90.00 in a report on Tuesday, May 5th. National Bank Financial dropped their price target on Nutrien from $76.00 to $74.00 and set an “outperform” rating for the company in a research note on Monday, August 10th. Finally, Oppenheimer cut their price target on shares of Nutrien from $82.00 to $80.00 and set an “outperform” rating on the stock in a report on Thursday, July 23rd. Seventeen analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $81.58.

Key Headlines Impacting Nutrien

Here are the key news stories impacting Nutrien this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $4.38 from $3.66, a substantial improvement that suggests stronger expected profitability. The firm also lifted estimates for Q2 2027, Q4 2027, FY2026, FY2028, Q1 2027, Q3 2027, Q4 2026 and Q2 2028. Collectively, the revisions point to improving longer-term earnings expectations.
• Positive Sentiment: An investor article emphasizes the appeal of not missing another year of Nutrien’s dividend income, which may reinforce the stock’s attraction to income-oriented investors. You’ve Already Missed a Year of Dividends: Here’s Why I Wouldn’t Miss Another
• Neutral Sentiment: Nutrien’s estimated current-year EPS remains below the broader consensus at $4.71 versus $4.95, while FY2027 and FY2028 estimates are $4.38 and $4.23, respectively. This indicates improving expectations but not an across-the-board bullish outlook.
• Negative Sentiment: Zacks Research reduced its Q3 2026 EPS estimate to $0.78 from $0.92 and its Q1 2028 estimate to $0.63 from $0.76. These cuts signal potential near-term earnings pressure and could limit the stock’s upside.

Nutrien Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.